Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
CD Protein Inhibitors
Products
Products
Diseases
News
«
1
2
...
6
7
8
9
10
11
12
13
14
15
16
...
27
28
»
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
281
562
843
1124
1405
1686
1967
2248
2529
2810
hexameric CD95 ligand
(APO010) / Allarity Therap
indatuximab ravtansine
(BT-062) / Grifols
inixaciclib
(NUV-422) / Nuvation Bio
izuralimab
(XmAb23104) / Xencor
mupadolimab
(CPI-006) / Corvus Pharma
nezastomig
(REGN5678) / Regeneron
ontorpacept
(PF-07901800) / Pfizer
onvapegleukin alfa
(TransCon IL-2 β/γ) / Ascendis
pavurutamab
(AMG 701) / Amgen
pimivalimab
(JTX-4014) / Concentra Biosci
plamotamab
(XmAb13676) / Xencor
pradusinstobart
(LVGN3616) / Lyvgen
praluzatamab ravtansine
(CX-2009) / CytomX, AbbVie
rituximab biosimilar
(TL011) / Teva
rosnilimab
(ANB030) / AnaptysBio
samalizumab
(ALXN 6000) / The Leukemia & Lymphoma Society, AstraZeneca
sevuparin
(DF-02) / Modus Therap, Mahidol Oxford Tropical Medicine Research Unit
sudubrilimab
(HS636) / Zhejiang Hisun
tibremciclib
(BPI-16350) / Betta Pharma
vixtimotamab
(AMV564) / Affimed
vonsetamig
(REGN5459) / Regeneron
vopikitug
(RG6292) / Roche
xaluritamig
(AMG 509) / Amgen
177Lu-DTPA-omburtamab
/ Y-mAbs Therap
211At-OKT10-B10
/ Fred Hutchinson Cancer Center
225Ac-DOTA-daratumumab
/ City of Hope
90Y-besilesomab
(TLX66) / Telix
A-319
/ ITabMed
A-337
/ ITabMed
ABP-300
/ Abpro, BIO invest, Mabwell (Shanghai) Biosci
AFM11
/ Affimed
AGEN1777
/ Agenus
AGS67E
/ Astellas, Pfizer
AK129
/ Akesobio
AMP-224
/ GSK
AO-176
/ Arch Oncology
AOC-1044
/ Eli Lilly
AP203
/ AP Biosciences
ASP1002
/ Astellas
ATA3219
/ Atara
ATLCAR.CD30.CCR4 cells
/ UNC Lineberger Comprehensive Cancer Center
AUTO3
/ Autolus
AVX-701
/ AlphaVax
AdCD40L
/ Uppsala University
Anti CEA/CD30 CAR-T
/ Shanghai First Song Therap
Anti-CD19 CAR-T
/ First Affiliated Hospital of Nanchang University
Anti-CD22 CAR-T Cells
/ Beijing Boren Hospital
Antova
(ruplizumab) / Biogen
Autologous CAR-T cells
/ UTC Therap
BA1104
(nivolumab biosimilar) / Luye Group
«
1
2
...
6
7
8
9
10
11
12
13
14
15
16
...
27
28
»
